Anti-thyroid peroxidase antibody and vitiligo: a controlled study

Area of Science:

• Immunology
• Dermatology
• Endocrinology

Background:

• Vitiligo is an acquired depigmenting disorder linked to melanocyte destruction.
• Autoimmunity is a leading theory in vitiligo pathogenesis, supported by associations with autoimmune thyroid diseases.
• Increased prevalence of autoantibodies, including thyroid autoantibodies, in vitiligo patients further supports the autoimmune hypothesis.

Purpose of the Study:

• To compare the frequency of thyroid peroxidase antibody (anti-TPO) in vitiligo patients versus healthy individuals in Iran.
• To investigate potential correlations between anti-TPO and demographic factors in vitiligo patients.

Main Methods:

• A controlled study involving 94 vitiligo patients and 96 healthy controls, matched for age and gender.
• Exclusion of participants with pre-existing thyroid disease, thyroid surgery history, or current thyroid medication use.
• Assessment of anti-TPO levels, thyroid function tests (free T3, free T4, TSH), and recording of clinical data via questionnaires.

Main Results:

• Anti-TPO was detected in 18.1% of vitiligo patients compared to 7.3% in controls (p < 0.025).
• This significant difference was prominent in females (p < 0.044) and younger age groups (18-25 and 26-35 years).
• No significant differences in anti-TPO frequency were observed regarding vitiligo duration or extent, nor in thyroid function tests between groups.

Conclusions:

• Anti-TPO is significantly more prevalent in vitiligo patients, especially young women, indicating a potential autoimmune link.
• The presence of anti-TPO, a marker for autoimmune thyroid disorders, highlights the need for regular thyroid monitoring in vitiligo patients.
• Early detection of thyroid dysfunction is crucial, particularly in young women with vitiligo and elevated anti-TPO levels.